Real‐life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1‐year follow‐up data report

Background Progressive supranuclear palsy (PSP) is a progressive neurodegenerative condition presenting with different clinical endophenotypes. The parkinsonian variant of PSP (PSP‐P) is characterised by early but fading responsiveness to high‐dose levodopa therapy; however, high‐dose oral therapy i...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Brain and behavior Ročník 12; číslo 9; s. e2547 - n/a
Hlavní autori:	Metta, Vinod, Chaudhuri, K. Ray, Leta, Valentina, Mridula, Kandadai Rukmini, Koduri, Chaitanya, Deepak, Sai, Kalpala, Rakesh, Reddy, Nageswar, Chung‐Faye, Guy, Borgohain, Rupam
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States John Wiley & Sons, Inc 01.09.2022 John Wiley and Sons Inc Wiley
Predmet:	Antiparkinson Agents - therapeutic use Cosmetics Dementia Diabetes Dopamine Drug dosages Family medical history Follow-Up Studies Gait Hallucinations Hospitals Humans Hypertension intrajejunal levodopa‐carbidopa infusion Levodopa - adverse effects motor and nonmotor symptoms Original Parkinson Disease Parkinson's disease Parkinsonian variant of progressive supranuclear palsy Patients Quality of Life Sleep Supranuclear Palsy, Progressive India intrajejunal levodopa-carbidopa infusion Parkinsonian variant of progressive supranuclear palsy motor and nonmotor symptoms quality of life
ISSN:	2162-3279, 2162-3279
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!